secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2025-02-05T23:59:59+00:00
Accession:  0001493152-25-005043
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell raises $3.05M in public offering of 762,500 common shares at $4.00/share
--------------------------------------------------------------------------------

- Closed best-efforts offering of 762,500 common shares at $4.00/share on Feb 5, 2025; gross proceeds $3.05M.
- Net proceeds to be used for working capital, general corporate purposes, and advancement of business objectives.
- ThinkEquity acted as sole placement agent; received 7.5% cash fee and warrants to purchase 38,125 shares at $5.00/share (5-year term).
- Offering conducted under effective shelf registration S-3; TSX exemption relied upon for listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225005043/0001493152-25-005043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225005043/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-005043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer